| Nov 13 |
MEI Pharma GAAP EPS of -$1.20
|
| Nov 12 |
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position
|
| Oct 28 |
MEI Pharma stock jumps 8% on sale of drug asset ME-344
|
| Sep 19 |
MEI Pharma GAAP EPS of $2.67 misses by $0.95, revenue of $65.3M in-line
|
| Sep 19 |
MEI Pharma Reports Fiscal Year End 2024 Cash Position
|
| Aug 12 |
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
|
| Jul 23 |
Laidlaw cuts MEI Pharma to hold over shutdown concerns
|
| Jul 22 |
MEI Pharma plans workforce reduction as part of strategic alternatives
|
| Jul 22 |
MEI Pharma to Consider Strategic Alternatives
|
| Jul 1 |
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
|
